Your browser doesn't support javascript.
loading
In the literature: October 2021.
Gambardella, V; Martínez-Ciarpaglini, C; Fleitas, T; Cervantes, A.
Affiliation
  • Gambardella V; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
  • Martínez-Ciarpaglini C; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain; Department of Pathology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Fleitas T; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
  • Cervantes A; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: andres.cervantes@uv.es.
ESMO Open ; 6(6): 100285, 2021 12.
Article in En | MEDLINE | ID: mdl-34752996
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ESMO Open Year: 2021 Document type: Article Affiliation country: Spain Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ESMO Open Year: 2021 Document type: Article Affiliation country: Spain Country of publication: United kingdom